Feb 13, 2026, 10:57 PM IST AvanceTechnologies - Board Meeting Outcome for Outcome Of Board Meeting For Declaration Of Un-Audited Financial Results (Stan Feb 13, 2026, 10:50 PM IST AvanceTechnologies - ...

ADELAIDE, Australia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Avance Clinical, a global contract research organization focused on accelerating clinical development for biotech sponsors, today announced the ...

Avance Technologies has signed a non-binding term sheet to acquire up to 100% equity stake in Pushpak AI, a Hyderabad-based company specializing in Computer Vision and Edge AI platforms. The move ...

Avance Technologies has signed a non-binding term sheet to acquire upto 100% equity stake in Pushpak AI, a Hyderabad-based Computer Vision and Edge AI platform. The announcement comes amid rapid ...

Clinical trial findings showed Avance was noninferior to a collagen nerve cuff for returning sensory function in patients with nerve injuries in the hand. The Food and Drug Administration (FDA) has ...

Avance Biosciences has opened a 75,000-square-foot biomanufacturing facility in Northwest Houston. The facility will support the production of cell and gene therapies, vaccines, and other biologic ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The 75,000-square-foot building ...

(RTTNews) - Axogen, Inc. (AXGN) announced that the U.S. Food and Drug Administration has approved the Biologics License Application (BLA) for AVANCE, an acellular nerve allograft (arwx). AXGN closed ...

ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of ...

The U.S. FDA granted accelerated approval for the Biologics License Application for Axogen Inc.'s Avance, an acellular nerve allograft that serves as a scaffold for nerve regrowth, for treatment of ...